VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155 | -37.5% | 5,752 | -30.3% | 0.01% | -38.1% |
| Q2 2023 | $248 | -7.1% | 8,252 | 0.0% | 0.02% | -27.6% |
| Q1 2023 | $267 | +12.7% | 8,252 | 0.0% | 0.03% | +3.6% |
| Q4 2022 | $237 | -99.8% | 8,252 | +68.9% | 0.03% | +86.7% |
| Q3 2022 | $118,000 | -11.9% | 4,887 | 0.0% | 0.02% | -6.2% |
| Q2 2022 | $134,000 | -29.5% | 4,887 | -1.3% | 0.02% | -20.0% |
| Q1 2022 | $190,000 | +21.0% | 4,949 | +1.3% | 0.02% | +33.3% |
| Q4 2021 | $157,000 | +9.0% | 4,887 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $144,000 | -13.3% | 4,887 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $166,000 | +4.4% | 4,887 | 0.0% | 0.02% | -5.6% |
| Q1 2021 | $159,000 | -9.7% | 4,887 | 0.0% | 0.02% | -14.3% |
| Q4 2020 | $176,000 | -13.3% | 4,887 | -5.8% | 0.02% | -32.3% |
| Q3 2020 | $203,000 | – | 5,187 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |